Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

JOHNSON & JOHNSON (JNJ)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 3
  • 1 comments

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida

Market reaction Comment Full text

SINOVAC BIOTECH LTD (SVA)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 2
  • 1 comments

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements

Market reaction Comment Full text

OUSTER, INC. (OUST)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 3
  • 1 comments

Ouster and Benchmark Expand Partnership to Scale Volume Production of New REV8 Digital Lidar Sensors

Market reaction Comment Full text

NIP GROUP INC. (NIPG)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 3
  • 1 comments

NIP Group Inc. Announces Plan to Implement ADS Ratio Change

Market reaction Comment Full text

OBOOK HOLDINGS INC. (OWLS)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 2
  • 1 comments

OwlTing Group (NASDAQ: OWLS) and Credible Finance Partner to Open China Payment Corridor

Market reaction Comment Full text

Fennec Pharmaceuticals Inc (FENC)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 2
  • 1 comments

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Market reaction Comment Full text

KRISPY KREME, INC. (DNUT)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 2
  • 1 comments

KRISPY KREME® Brings the Sweet Taste of Summer with All-New Seasonal Collection

Market reaction Comment Full text

AMERICANN INC. (ACAN)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 2
  • 1 comments

Acanthe Developpement : Communiqué de mise à disposition du rapport sur le gouvernment dentreprise

Market reaction Comment Full text

IDEAYA BIOSCIENCES, INC. (IDYA)

  • Business News
  • June 15, 2026, 10:00 UTC
  • 4
  • 1 comments

IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers

Market reaction Comment Full text

FRASER AND NEAVE LIMITED. (F99)

  • Business News
  • June 15, 2026, 09:58 UTC
  • 1
  • 0 comments

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

Market reaction Comment Full text
  • Previous
  • 2812
  • 2813
  • 2814
  • 2815
  • 2816
  • Next

Search

News categories

  • Technical Exchange News(14168)
  • Event(6229)
  • SEC News(361397)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222242)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin